These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8044943)

  • 1. Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy.
    Steinberg JS; Hochman JS; Morgan CD; Dorian P; Naylor CD; Theroux P; Topol EJ; Armstrong PW
    Circulation; 1994 Aug; 90(2):746-52. PubMed ID: 8044943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators).
    Langer A; Goodman SG; Topol EJ; Charlesworth A; Skene AM; Wilcox RG; Armstrong PW
    J Am Coll Cardiol; 1996 May; 27(6):1327-32. PubMed ID: 8626939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal-averaged ECG prior to and serially after thrombolytic therapy for acute myocardial infarction.
    Beauregard LA; Waxman HL; Volosin R; Volosin KJ; Kurnik PB
    Pacing Clin Electrophysiol; 1996 Jun; 19(6):883-9. PubMed ID: 8774817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between infarct artery patency at late angiography after acute myocardial infarction and signal-averaged electrocardiography.
    Chandrasekaran S; Hochman JS; Slater JN; Palazzo AM; Morgan CD; Steinberg JS
    Am J Cardiol; 1999 Sep; 84(6):734-6, A8. PubMed ID: 10498147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated ST-segment reduction after thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) compared to urokinase.
    Derad I; Stierle U; Giannitsis E; Potratz J; Born J; Djonlagic H; Fehm HL
    Jpn Heart J; 1996 Jan; 37(1):33-41. PubMed ID: 8632624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction. European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator.
    Willems JL; Willems RJ; Willems GM; Arnold AE; Van de Werf F; Verstraete M
    Circulation; 1990 Oct; 82(4):1147-58. PubMed ID: 2119263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.
    Vanderschueren S; Barrios L; Kerdsinchai P; Van den Heuvel P; Hermans L; Vrolix M; De Man F; Benit E; Muyldermans L; Collen D
    Circulation; 1995 Oct; 92(8):2044-9. PubMed ID: 7554180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group.
    Topol EJ; Califf RM; Vandormael M; Grines CL; George BS; Sanz ML; Wall T; O'Brien M; Schwaiger M; Aguirre FV
    Circulation; 1992 Jun; 85(6):2090-9. PubMed ID: 1591828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of myocardial infarct artery patency on the prevalence of ventricular arrhythmia and late potentials after thrombolysis in acute myocardial infarction.
    Aguirre FV; Kern MJ; Hsia J; Serota H; Janosik D; Greenwalt T; Ross AM; Chaitman BR
    Am J Cardiol; 1991 Dec; 68(15):1410-6. PubMed ID: 1746420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study.
    Baran KW; Nguyen M; McKendall GR; Lambrew CT; Dykstra G; Palmeri ST; Gibbons RJ; Borzak S; Sobel BE; Gourlay SG; Rundle AC; Gibson CM; Barron HV;
    Circulation; 2001 Dec; 104(23):2778-83. PubMed ID: 11733394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LATE assessment of thrombolytic efficacy with alteplase (rt-PA) six-24 hours after onset of acute myocardial infarction.
    Bett JH
    Aust N Z J Med; 1993 Dec; 23(6):745-8. PubMed ID: 8141717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group.
    Lenderink T; Simoons ML; Van Es GA; Van de Werf F; Verstraete M; Arnold AE
    Circulation; 1995 Sep; 92(5):1110-6. PubMed ID: 7648654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pre-infarction angina on ventricular late potentials in patients with acute myocardial infarction and successful thrombolysis.
    Evrengul H; Kayikcioglu M; Can L; Payzin S; Kultursay H
    Acta Cardiol; 2003 Aug; 58(4):295-301. PubMed ID: 12948034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study Group.
    Morgan CD; Gent M; Daly PA; Baigrie RS; Haq A; Roberts RS; Armstrong PW
    Can J Cardiol; 1994 Nov; 10(9):897-904. PubMed ID: 7954025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appearance of abnormal Q waves early in the course of acute myocardial infarction: implications for efficacy of thrombolytic therapy.
    Raitt MH; Maynard C; Wagner GS; Cerqueira MD; Selvester RH; Weaver WD
    J Am Coll Cardiol; 1995 Apr; 25(5):1084-8. PubMed ID: 7897120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction.
    Zeymer U; Schröder R; Machnig T; Neuhaus KL
    Am Heart J; 2003 Oct; 146(4):686-91. PubMed ID: 14564324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of statin therapy on ventricular late potentials in acute myocardial infarction.
    Kayikcioglu M; Can L; Evrengul H; Payzin S; Kultursay H
    Int J Cardiol; 2003 Jul; 90(1):63-72. PubMed ID: 12821221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early thrombolytic treatment reduces analgesic requirement in patients with myocardial infarction.
    Kristensen KS; Haarbo J; Munkvad S; Stoltenberg M
    J Intern Med; 1991 Mar; 229(3):257-9. PubMed ID: 1901076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of high-frequency analysis of signal-averaged surface electrocardiograms in acute myocardial infarction before and after coronary thrombolysis for assessing coronary reperfusion.
    Tranchesi B; Verstraete M; Van de Werf F; de Albuquerque CP; Caramelli B; Gebara OC; Pereira WI; Moffa P; Bellotti G; Pileggi F
    Am J Cardiol; 1990 Nov; 66(17):1196-8. PubMed ID: 2122705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.